We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Ultrasound Exam Could Reduce Breast Biopsies

By HospiMedica staff writers
Posted on 15 May 2002
If ultrasound is used to detect breast cancer, it may lead to a reduction in the number of biopsies needed, according to a study conducted by researchers at the University of Michigan (Ann Arbor, USA).

The study involved 141 women with 157 solid masses. More...
Of these, 59 were identified by mammography or magnetic resonance imaging (MRI), and 98 were palpable. Ultrasound examinations were then performed by 11 radiologists specializing in breast imaging, who classified the masses prospectively as either benign or suspicious. In addition, they classified the masses by previously published criteria (Stavros criteria) that set guidelines for how a benign mass and a malignant mass appear on ultrasound.

The results showed that if the follow-up of patients had been based on the radiologists' diagnoses following ultrasound, 38 fewer biopsies would have been performed, reducing the biopsy rate by 28%. Moreover, no cancers would have been missed, since the radiologists classified all 55 cancers as suspicious based both on their own criteria and the Stavros criteria.

"With larger numbers of masses evaluated, we expect that a few cancers may appear benign on ultrasound,” noted Karen Hunt, M.D., senior staff radiologist at Henry Ford Hospital in Ann Arbor and lead author of the study. "We expect this to be quite rare, so imaging surveillance can be safely offered as an alternative to biopsy. Ultrasound is a reliable test that should be part of the approach to diagnosing these patients.” The study was presented at the annual meeting of the American Roentgen Ray Society in Atlanta (ARRS, GA, USA; www.arrs.org).




Related Links:
American Roentgen Ray Society

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.